Guerbet SA (LON: 0ELV)

Market Cap	288.44M
Revenue (ttm)	712.83M
Net Income (ttm)	27.78M
Shares Out	n/a
EPS (ttm)	2.20
PE Ratio	10.38
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Jul 1, 2024

Volume	6
Average Volume	67
Open	27.60
Previous Close	27.65
Day's Range	27.60 - 27.60
52-Week Range	15.70 - 32.50
Beta	0.76
RSI	55.15
Earnings Date	Mar 25, 2025

About Guerbet

Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1926
• Employees: 2,920
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0ELV

Financial Performance

Financial numbers in EUR